E-LIB Suche - Ergebnisse für: Schwenk, Robert J

1

Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozo..:

Khan, Farhat ; Porter, Mike ; Schwenk, Robert...
PLOS ONE. 10 (2015) 11 - p. e0142035 , 2015

Link: https://doi.org/10.1371/..

2

IgG2 Antibodies against a Clinical Grade Plasmodium falcipa..:

Schwenk, Robert ; DeBot, Margot ; Porter, Michael...
PLoS ONE. 9 (2014) 10 - p. e111020 , 2014

Link: https://doi.org/10.1371/..

3

Ex vivo tetramer staining and cell surface phenotyping for ..:

Schwenk, Robert ; Banania, Glenna ; Epstein, Judy...
Malaria Journal. 12 (2013) 1 - p. , 2013

Link: https://doi.org/10.1186/..

4

Protective Immunity Induced with the RTS,S/AS Vaccine Is As..:

Lumsden, Joanne M. ; Schwenk, Robert J. ; Rein, Lisa E....
PLoS ONE. 6 (2011) 7 - p. e20775 , 2011

Link: https://doi.org/10.1371/..

5

Protective immunity to pre-erythrocytic stage malaria:

Schwenk, Robert J. ; Richie, Thomas L.
Trends in Parasitology. 27 (2011) 7 - p. 306-314 , 2011

Link: https://doi.org/10.1016/..

6

Immunization with the RTS,S/AS malaria vaccine induces IFN-..:

Schwenk, Robert ; Lumsden, Joanne M. ; Rein, Lisa E....
Vaccine. 29 (2011) 48 - p. 8847-8854 , 2011

Link: https://doi.org/10.1016/..

7

Recombinant Liver Stage Antigen-1 (LSA-1) formulated with A..:

Cummings, James F. ; Spring, Michele D. ; Schwenk, Robert J....
Vaccine. 28 (2010) 31 - p. 5135-5144 , 2010

Link: https://doi.org/10.1016/..

8

Randomized, Double-Blind, Phase 2a Trial of Faltiparum Mala..:

Kester, Kent E. ; Cummings, James F. ; Ofori-Anyinam, Opokua...
The Journal of Infectious Diseases. 200 (2009) 3 - p. 337-346 , 2009

Link: https://www.jstor.org/st..

9

Immunization with Radiation-Attenuated Plasmodium berghei S..:

Jobe, Ousman ; Donofrio, Gina ; Sun, Guangping...
PLoS ONE. 4 (2009) 4 - p. e5075 , 2009

Link: https://doi.org/10.1371/..

10

Randomized, Double‐Blind, Phase 2a Trial of Falciparum Mala..:

Kester, Kent E. ; Cummings, James F. ; Ofori‐Anyinam, Opokua...
The Journal of Infectious Diseases. 200 (2009) 3 - p. 337-346 , 2009

Link: https://doi.org/10.1086/..

11

Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day im..:

Kester, Kent E. ; Cummings, James F. ; Ockenhouse, Christian F....
Vaccine. 26 (2008) 18 - p. 2191-2202 , 2008

Link: https://doi.org/10.1016/..

12

Genetically AttenuatedPlasmodium bergheiLiver Stages Induce..:

Jobe, Ousman ; Lumsden, Joanne ; Mueller, Ann‐Kristin...
The Journal of Infectious Diseases. 196 (2007) 4 - p. 599-607 , 2007

Link: https://doi.org/10.1086/..

13

A phase I/IIa safety, immunogenicity, and efficacy bridging..:

Kester, Kent E. ; McKinney, Denise A. ; Tornieporth, Nadia...
Vaccine. 25 (2007) 29 - p. 5359-5366 , 2007

Link: https://doi.org/10.1016/..

14

The dog that did not bark: malaria vaccines without antibod..:

Heppner, D. Gray ; Schwenk, Robert J. ; Arnot, David..
Trends in Parasitology. 23 (2007) 7 - p. 293-296 , 2007

Link: https://doi.org/10.1016/..

15

Genetically Attenuated Plasmodium berghei Liver Stages Indu..:

Jobe, Ousman ; Lumsden, Joanne ; Mueller, Ann-Kristin...
The Journal of Infectious Diseases. 196 (2007) 4 - p. 599-607 , 2007

Link: https://www.jstor.org/st..